Relationship
type: Class

Anualidad
type: Class

Provision of Service
type: Class

Continuant
type: Class

Entity
type: Class

Process
type: Class

Project
type: Class

Occurrent
type: Class

Specifically Dependent Continuant
type: Class

2007
type: Class

Grant
type: Class

Project
type: Class

RDF description of SAL\1385 - http://research.umh.es/vivo/pub/proyecto/SAL1385
type: Document
rights: termsOfUse
date: 2026-08-14T18:55:36
publisher: SAL\1385

SAL\1385
type: 2007
relates: FERRER MONTIEL, ANTONIO VICENTE
description: EVALUACION DE LA CARDITOXICIDAD IN VIVO DE LA FORMULACION DEL ANTITUMORAL DOXORRUBICINA EN LIPOSOMAS
codigo: 1385S
BFO_0000055: Principal Investigator on SAL1385
type: Provision of Service
geographic focus: national
referencia: SAL\1385
most specific type: 2007
type: Entity
type: Anualidad
type: Thing
type: Project
type: Continuant
type: Relationship
most specific type: Provision of Service
most specific type: Grant
date time interval: SAL1385 date
type: Process
presupuesto: 5900.0
type: Occurrent
type: Grant
type: Specifically Dependent Continuant
investigadores: 1
otricodigo: PSDQ26
relates: Principal Investigator on SAL1385

FERRER MONTIEL, ANTONIO VICENTE
type: PersonActive
type: Agent
type: Entity
type: Person
type: Thing
type: BFO_0000004
type: Continuant
related by: SAL\1385

Principal Investigator on SAL1385
type: BFO_0000017
type: ResearcherRole
type: PrincipalInvestigatorRole
type: InvestigatorRole
type: Specifically Dependent Continuant
type: BFO_0000023
type: Entity
type: Thing
related by: SAL\1385
type: Continuant
BFO_0000054: SAL\1385